Safety considerations of current drug treatment strategies for nosocomial pneumonia
A Ceccato, P Di Giannatale, SNogas… - Expert Opinion on Drug …, 2021 - Taylor & Francis
Introduction: Nosocomial pneumonia unfortunately remains a frequent event for which
appropriate antibiotic treatment is central to improving outcomes. Physicians must choose an …
appropriate antibiotic treatment is central to improving outcomes. Physicians must choose an …
Impact of cardiovascular failure in intensive care unit-acquired pneumonia: a single-center, prospective study
…,M Carbonara,G li Bassi, P di Natale, SNogas… - Antibiotics, 2021 - mdpi.com
Background: Cardiovascular failure (CVF) may complicate intensive care unit-acquired
pneumonia (ICUAP) and radically alters the empirical treatment of this condition. The aim of this …
pneumonia (ICUAP) and radically alters the empirical treatment of this condition. The aim of this …
Prediction of ventilator-associated pneumonia outcomes according to the early microbiological response: a retrospective observational study
…,OT Ranzani, G De Pascale, SNogas… - European …, 2022 - Eur Respiratory Soc
Background Ventilator-associated pneumonia (VAP) is a leading infectious cause of morbidity
in critically ill patients, yet current guidelines offer no indications for follow-up cultures. We …
in critically ill patients, yet current guidelines offer no indications for follow-up cultures. We …
[HTML][HTML]现实世界的皮质类固醇使用在严重肺炎:a propensity-score-matched study
…,A Gabarrus, P Di Giannatale, SNogas… - Critical …, 2021 - ccforum.biomedcentral.com
Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide
despite correct antibiotic use. Corticosteroids have long been evaluated as a treatment …
despite correct antibiotic use. Corticosteroids have long been evaluated as a treatment …
Neuromonitoring during general anesthesia in non-neurologic surgery
…, F Iannuzzi, S Amodio, M Mandelli, SNogas… - Best Practice & …, 2021 - Elsevier
Cerebral complications are common in perioperative settings even in non-neurosurgical
procedures. These include postoperative cognitive dysfunction or delirium as well as …
procedures. These include postoperative cognitive dysfunction or delirium as well as …
Corticosteroids in severe pneumonia. A propensity score matching study based on real-life
…, G Tiseo,A Gabarrus, P Di Giannatale, SNogas… - 2021 - Eur Respiratory Soc
Community-acquired pneumonia (CAP) is a leading cause of mortality and morbidity worldwide
despite correct antibiotic use. In CAP, corticosteroids have long been evaluated yielding …
despite correct antibiotic use. In CAP, corticosteroids have long been evaluated yielding …
Procedures and definitions
…,C Cillóniz, OT Ranzani, G De Pascale, SNogas… - Eur Respiratory Soc
…Stefano
Nogas8, Pierluigi Di Giannatale9, Massimo Antonelli3,4, Antoni Torres1,5 …
Use of corticosteroids in patients with severe CAP admitted to ICU, experience in a real-life setting
A Ceccato, PL Di Giannatale, E Barbeta, SNogas… - 2020 - Eur Respiratory Soc
There are controversies about the use of corticosteroids in severe community-acquired
pneumonia (CAP). Despite several meta-analyses have shown reduce mortality, last ATS/IDSA …
pneumonia (CAP). Despite several meta-analyses have shown reduce mortality, last ATS/IDSA …
Novel swine ARDS model induced by Pseudomonas aeruginosa pneumonia and VILI
…, R Cabrera, CR Vargas, P Di Ginnatale, SNogas… - 2020 - Eur Respiratory Soc
Background: Translational animal models of acute respiratory distress syndrome (ARDS) do
not completely reproduce all features of human ARDS 1 . These models are usually rapidly …
not completely reproduce all features of human ARDS 1 . These models are usually rapidly …
Are carbapenems a better antibiotic than others for treat ICU-AP? A post-hoc analysis of a prospective cohort
A Ceccato, PL Di Giannatale, SNogas,A Gabarrus… - 2020 - Eur Respiratory Soc
There are controversies about non-inferiority of treatment with non-carbapenem β-lactams
and carbapenems in patients with infections caused by ESBL enterobacterias. In guidelines …
and carbapenems in patients with infections caused by ESBL enterobacterias. In guidelines …